00000001|Abortifacients|01
00000002|Angiotensin Converting Enzyme (ACE) Inhibitors|00
00000003|Acne Antibiotics|00
00000004|Acne Cleansers|02
00000005|Acne Products|03
00000006|Actinic Keratoses Agents|00
00000007|Adenosine|00
00000008|Adrenal Steroid Inhibitors|00
00000009|Alcohol-Sensitizing Agents|00
00000010|Aldose Reductase Inhibitors|00
00000011|Alkyl Sulfonates|00
00000012|Alpha-Blockers|00
00000013|Alpha-Glucosidase Inhibitor|00
00000015|Alprostadil|00
00000017|Alzheimer's Disease Agents|00
00000018|Amebicides, Systemic|00
00000019|Aminoglycosides, Parenteral|00
00000020|Amphetamines/Anorexiants/Stimulants|00
00000023|Androgens/Anabolic Steroids|00
00000025|Angiotensin II Receptor Antagonists (ARBs)|00
00000026|Antacids|01
00000027|Anthelmintics|00
00000028|Anthracycline Antibiotics|00
00000031|Antiandrogen|00
00000032|Antianxiety Agents|00
00000033|Antiarrhythmic - Class IA|00
00000034|Antiarrhythmic - Class IB (Systemic)|00
00000035|Antiarrhythmic - Class IC|00
00000036|Antiarrhythmic - Class III|00
00000038|Anticholinergic Antispasmodics|00
00000039|Ophthalmic Anticholinesterase Miotics|00
00000040|Anticonvulsants|02
00000041|Antidepressants|00
00000042|Antidiuretic Hormone|00
00000043|Antiemetic|01
00000044|Antiestrogen|00
00000045|Antiflatulents|01
00000046|Antifungals-Systemic|00
00000051|Antihypertensive MAO Inhibitors (MAOIs)|00
00000054|Antimyasthenic Agents|00
00000056|Antineoplastic Monoclonal Antibodies|00
00000057|Antiparkinsonian Anticholinergic Agents|00
00000058|Antiparkinsonian COMT Inhibitors|00
00000059|Antiparkinsonian Dopamine Agonists|00
00000060|Antiparkinsonian MAO Inhibitors (MAOIs)|00
00000061|Antiperistaltic Agents|00
00000064|Antiprotozoal Agents|00
00000066|Antipsoriatics|00
00000067|Antipsychotics|00
00000071|Antithyroid Agents|00
00000073|Antiviral - CMV Infection|00
00000074|Antiviral - Herpes Viruses|00
00000075|Antiviral - Influenza A|00
00000076|Antiviral-HIV (Antiretroviral)  Nonnucleoside RT Inhibitor|00
00000077|Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors|02
00000078|Antiviral-HIV (Antiretroviral) Protease Inhibitors|00
00000079|Aromatase Inhibitors|00
00000084|Asparaginase Enzyme Therapy Agents|00
00000088|Bacitracin|00
00000091|Benzodiazepine Antagonists|00
00000093|Benzodiazepines|00
00000094|Beta-Adrenergic Agents|00
00000096|Beta-Lactams|00
00000097|Bicarbonates|00
00000098|Biguanides|00
00000101|Bismuth Salts|00
00000106|Calcium|00
00000107|Calcium Channel Blockers|01
00000109|Carbonic Anhydrase Inhibitors|00
00000113|Central Muscle Relaxants|00
00000114|Cerebral Vasodilators|00
00000116|Chloramphenicol and Derivatives|00
00000127|Contraceptives|00
00000129|Corticotropins|00
00000130|Ophthalmic Cycloplegics/Mydriatics|00
00000132|Dacarbazine|00
00000144|Diphtheria Toxoid|00
00000146|Diuretics|02
00000153|Antineoplastic - Epipodophyllotoxins|00
00000154|Ergoloid Mesylates|00
00000155|Erythropoiesis-Stimulating Agents|00
00000157|Estrogens|00
00000159|Factor IX|00
00000160|Factor VII|00
00000162|Fluorides|00
00000163|Folic Acid|00
00000164|Furazolidone|00
00000165|Gallstone Solubilizing Agents|00
00000168|GI Stimulants|00
00000172|Glucocorticosteroids|00
00000175|Glycoprotein IIB/IIIA Receptor Inhibitor|00
00000176|LHrH(GNrH) Antagonist, Pituitary Suppressant Agents|00
00000177|Gold Compounds|00
00000182|Haemophilus B Vaccine|00
00000186|Heparin|00
00000189|Hepatitis B Vaccine|00
00000191|Anticonvulsant - Hydantoins|00
00000193|Hypercalcemia Agents|00
00000197|Impotence Agents, non-specific other|00
00000200|Influenza Vaccine|00
00000202|Hypoglycemics, Insulin-Response Enhancer-Thiazolidinediones|00
00000204|Interferon Alfa|00
00000207|Interleukin 2|00
00000208|Intermittent Claudication Agents|00
00000213|Iodine|00
00000214|Iron|00
00000220|Lead Poisoning Agents|00
00000221|Antileprotics (Systemic multi-ingredient)|01
00000222|Leukocyte Stimulating Factors|00
00000223|Leukotriene Modulators|00
00000226|LHrH(GNrH) Agonist Analog Pituitary Suppressants|00
00000235|Macrolide Antibiotics|00
00000237|Magnesium|00
00000239|Measles Vaccine|00
00000245|Methylene Blue|00
00000248|Migraine Products|00
00000249|Mineralocorticoids|00
00000254|Monoclonal Antibody Immunosuppressives|00
00000259|Mumps Vaccine|00
00000261|Opioid Antagonists|00
00000266|Nasal Mast Cell Stabilizers|00
00000271|Nitrates|00
00000272|Nitrogen Mustard Derivatives|00
00000273|Nitroimidazole Antibiotics|00
00000274|Nitrosoureas|00
00000276|Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates|00
00000281|Ophthalmic Adrenergic Agents|00
00000283|Ophthalmic Antibacterials|00
00000284|Ophthalmic Antifungals|00
00000285|Ophthalmic Antiseptics|00
00000286|Ophthalmic Antivirals|00
00000287|Ophthalmic Beta-Blockers|00
00000288|Ophthalmic Carbonic Anhydrase Inhibitors|00
00000289|Ophthalmic Decongestants|00
00000294|Ophthalmic NSAIDS|00
00000295|Ophthalmic Prostaglandin Agonists|00
00000296|Ophthalmic Steroids|00
00000297|Oral Aminoglycosides|00
00000298|Oral Anticoagulants|00
00000299|Osmotic Diuretics|00
00000300|Osteoporosis Agents|00
00000302|Otic Antibiotics|00
00000303|Otic Antifungals|00
00000304|Otic Steroids|00
00000306|Oxazolidinediones|00
00000307|Oxytocics|01
00000309|Parasympathetic Miotics|00
00000313|Peptic Ulcer Agents|00
00000314|Periodontal Pocket Anti-Infectives|00
00000317|Pertussis Vaccine|00
00000319|Phosphate Binder Agents|00
00000320|Phosphates|00
00000327|Platinum Compounds|00
00000329|Poliovirus Vaccine|00
00000330|Polymyxins|00
00000331|Potassium|00
00000332|Potassium-Removing Resins|00
00000333|Potassium-Sparing Diuretics|00
00000335|Precocious Puberty Agents|00
00000338|Progestins|00
00000339|Prolactin Inhibitors|00
00000342|Pseudomembranous Colitis Agents|00
00000344|Purine Analogues|00
00000346|Quinine|00
00000347|Quinolones|00
00000349|Rabies Vaccines|00
00000350|Rauwolfia Alkaloids|00
00000355|Ribavirin|00
00000357|Rifamycins|00
00000359|Rubella Vaccine|00
00000369|Smoking Deterrents, other|02
00000375|Steroids - Mouth|00
00000376|Stimulant Laxatives|01
00000378|Sulfonamides|00
00000379|Hypoglycemics - Sulfonylureas and Related Non-Sulfonylureas|00
00000385|Tetanus Immune Globulin|00
00000386|Tetanus Toxoid|00
00000387|Tetracyclines|00
00000389|Thrombolytic Agents|00
00000391|Thyroid Hormones|00
00000392|Tocolytics|00
00000397|Topical Antihistamines|00
00000399|Topical Corticosteroids|00
00000408|Trimethoprim|00
00000412|Uricosurics|00
00000416|Urinary Tract Anti-Infectives|00
00000419|Thiol-Type Renal/Tissue Protectants|00
00000421|Vaginal Anti-Infectives|00
00000422|Vaginal Estrogens|00
00000425|Anticonvulsant - Valproic Acid|00
00000426|Vancomycin Intravenous|00
00000428|Vasodilators|00
00000430|Visco-Elastics, Intraocular|00
00000431|Vitamin A|00
00000432|Vitamin B-1|00
00000433|Vitamin B-2|00
00000435|Vitamin B-5|00
00000436|Vitamin B-6|00
00000437|Vitamin C|00
00000438|Vitamin D|00
00000439|Vitamin E|00
00000440|Vitamin K|00
00000441|General Anesthetics, Inhalant|00
00000442|Xanthines|00
00000443|Yellow Fever Vaccine|00
00000446|Zinc, Systemic|00
00000447|Cephalosporins|00
00000448|Cephalosporins - 1st Generation|00
00000449|Cephalosporins - 2nd Generation|00
00000450|Cephalosporins - 3rd Generation|00
00000451|Alpha-Beta Blockers|00
00000452|Carbapenems (All)|00
00000453|Extended Spectrum Penicillins|00
00000454|Extended Spectrum Antibiotics|00
00000455|Penicillins|00
00000456|Cephalosporins - 4th Generation|00
00000457|Ophthalmic Parasympathetic Agents|00
00000458|Phenothiazines|00
00000459|Ophthalmic Sympatholytic Agents|00
00000460|Butyrophenones|00
00000461|Thioxanthenes|00
00000463|Antipsychotic Benzamides|00
00000464|Antipsychotic Diphenylbutylpiperidines|00
00000465|Antipsychotic Dihydroindolones|00
00000466|Antipsychotics, Atypical|00
00000467|Antipsychotic Dopamine/Serotonin Antagonists|00
00000468|Antipsychotic Iminodibenzyl Derivatives|00
00000469|Vaginal Sulfonamides|00
00000470|Mucous Membrane Protectants|00
00000471|Visco-Elastics, Intra-articular|00
00000473|Ophthalmic Aminoglycosides|00
00000474|Vaginal Corticosteroids|00
00000475|Dental Corticosteroids|00
00000476|Histamine-2 Receptor Antagonists (H2 Antagonists)|00
00000477|Proton Pump Inhibitors|00
00000478|Digitalis Glycosides|00
00000479|Otic Antiseptics|00
00000480|5 Fluoropyrimidines|00
00000482|Fibric Acid Derivatives|00
00000483|Antihyperlipidemics HMGCo-A Reductase Inhibitors (Statins)|00
00000493|Antirheumatic Agents (DMARDS, non-Biologic)|02
00001015|Dental Fluoride Products|00
00001019|Digestive Enzymes|00
00001020|Alpha-Proteinase Inhibitors|00
00001021|Oral Topical Anesthetics|00
00001025|Multivitamins|00
00001026|Coal Tar Products|00
00001028|Astringents|00
00001029|Bile Sequestrants|00
00001030|Bulk Laxatives|00
00001031|Cauterizing Agents|00
00001033|Intravenous Anesthetics|00
00001034|Local Anesthetics - Parenteral|00
00001036|Topical Local Anesthetics|00
00001037|Ophthalmic Local Anesthetics|00
00001040|Expectorants|01
00001041|GI Absorbants|00
00001042|Growth Hormone Modulators|00
00001044|Hydrocholeretics|00
00001045|Interstitial Cystitis Agents|00
00001047|Lubricant Laxatives|00
00001049|Mouth and Throat Antifungal Agents|00
00001052|Urea Cycle Disorder Agents|00
00001054|Antitussives|00
00001057|Oral Decongestants|00
00001058|Antihistamines|00
00001059|Ophthalmic Antiglaucoma Agents|02
00001061|Antimalarial Drugs|01
00001063|Antiplatelet Drugs-excluding ASA 325 mg and below|00
00001065|Beta-Blockers (Systemic)|00
00001069|Ophthalmic Antiallergic Agents|00
00001070|Otic Analgesics|00
00001071|Rectal Steroids|00
00001072|Intrarectal Steroids|00
00001073|Rectal Local Anesthetics|00
00001074|Topical Antibiotics|00
00001075|Topical Antifungals|00
00001076|Topical Antivirals|00
00001079|Topical Enzymes|00
00001082|Scabicides and Pediculocides|00
00001084|Emetics|00
00001085|Venosclerosing Agents|00
00001086|Neuromuscular Blockers|00
00001087|Anticonvulsant - Succinimides|00
00001088|Hypnotics|00
00001089|Inflammatory Bowel Agents|00
00001091|Topical Hemostatics|00
00001092|Antihemophilic Products|00
00001093|Antihemophilic Inhibitor Products|00
00001094|Plasma Expanders|00
00001095|Plasma Proteins|00
00001096|Diet Aids|00
00001097|Inotropic Agents|00
00001099|Pressors|00
00001101|Lung Surfactants|00
00001102|Urinary Antispasmodics|00
00001103|Urinary Acidifiers|00
00001104|Urinary Alkalinizers|00
00001105|Urinary Analgesics|00
00001106|Urinary Stone Agents|00
00001107|Prostatic Hypertrophy Agents, Other|01
00001108|Lipids|00
00001109|Lipotropics miscellaneous|03
00001110|Central Adrenolytics|00
00001111|Peripheral Adrenolytics|00
00001116|Peripheral Vasodilators|00
00001117|Mucolytics|00
00001118|Nasal Decongestants|00
00001119|Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents|00
00001120|Orally Inhaled Steroids|00
00001121|Hypertonic Laxatives|01
00001122|Laxatives|02
00001124|PEG - Electrolytes|00
00001125|Somatostatic Agents|00
00001127|Gastric Acidifiers|00
00001128|Cobalamines|00
00001130|Nasal Anticholinergics|00
00001131|Nasal Antihistamines|00
00001132|Thrombin Inhibitors (Non-Heparinoid)|00
00001135|Nootropics|00
00001136|Nasal Steroids|00
00001137|Amino Acids, Parenteral|00
00001139|Antithrombin Agents|00
00001141|Beta-Adrenergic Agents Short-Acting (Inhaled)|00
00001149|Macrolide Immunosuppressants - Topical|00
00001150|Antidepressants Tricyclic and related Non-Sel. RU Inhibitors|00
00001151|Antidepressant Selective Serotonin Reuptake Inhib. (SSRIs)|00
00001152|Antidepressants Alpha-2 Receptor Antagonists|00
00001154|Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)|00
00001155|Antidepressant Dopamine Norepinephrine Reuptake Inhibitors|00
00001156|Antidepressant Serotonin-2 Antagonist Reuptake Inhibitors|00
00001157|Selective Norepinephrine RU Inhibitors (Sel-NARI)|00
00001158|Antidepressant Serotonin Dopamine Reuptake Inhibitor (SDRIs)|00
00001160|Irritable Bowel Syndrome Agents|00
00001166|Non-Opioid Analgesic/Antipyretic, Non-Salicylate|00
00001169|Hyperuricemia Agents (non-uricosuric)|00
00001170|5 Alpha-Reductase Inhibitors|00
00001171|Angiotensin Inhibiting Agents|00
00001173|Tumor Necrosis Factor Inhibiting Agents|00
00001174|Antineoplastic - Topoisomerase I Inhibitors|00
00001175|Parenteral Solutions Containing Sodium|01
00001176|Parenteral Solutions Containing Dextrose|01
00001177|Antitussives (Opioid Antitussives and DM)|00
00001178|Vinca Alkaloids and Analogs|00
00001181|Monoamine Oxidase Inhibitors (MAOIs)|00
00001182|Vaginal Antifungal Agents|00
00001183|Short-Acting Insulins|00
00001184|Intermediate-, Long-acting, and Combination Insulins|00
00001185|Antineoplastic - Taxanes|00
00001186|Lithium|00
00001187|Clindamycin Systemic|00
00001188|Clindamycin Topical|00
00001189|Clindamycin Vaginal|00
00001190|Alkylating Agents|00
00001191|Immunosuppress., T-Cell Fxn Inhibiting Monoclonal Antibodies|00
00001192|Capreomycin and Parenteral Aminoglycosides|00
00001193|Isoniazids|00
00001194|Cycloserines|00
00001195|Thioamides|00
00001196|Pyrazinamide|00
00001197|Ethambutol|00
00001198|Aminosalicylic Acid|00
00001199|Immunosuppressive Inosine Monophosphate Dehydrogenase Inhib.|00
00001200|Antibiotics with Anaerobic Coverage|00
00001201|Antiparkinsonian Levodopa Formulations|00
00001203|Bleomycin|00
00001204|Agents to Treat Resistant Gram Positive Organisms|00
00001205|Copper|00
00001206|Manganese|00
00001208|Pyrimidine Analogs|00
00001209|Drugs To Treat Hereditary Tyrosinemia|00
00001210|Fat Absorption Decreasing Agents|00
00001211|Procarbazine|00
00001212|Dactinomycin|00
00001213|Dantrolene|00
00001215|Denileukin Diftitox|00
00001216|Alzheimer's Disease Agents-NMDA Receptor Antagonists|00
00001219|Antiviral - CMV Infection-Eye Implant|00
00001220|Thrombopoietic Growth Factors|00
00001221|Antiretroviral - Fusion Inhibitors|00
00001222|Mitomycin - systemic|00
00001223|Mitotane|00
00001224|Glucosylceramide Synthase (GCS) Inhibitors|00
00001225|Guanidine HCl|00
00001226|Antiviral Monoclonal Antibodies|00
00001227|Growth Hormone Receptor Antagonists|00
00001229|Drugs to Treat Alcoholism|00
00001231|Physostigmine Injection|00
00001232|Aminocaproic Acid|00
00001233|Antineoplastic - EGFR Inhibitors, Monoclonal Antibodies|00
00001234|Cyclic Lipopeptides|00
00001237|Rho(D) Immune Globulins|00
00001238|Spectinomycin HCl|00
00001239|Metabolic Disease Enzyme Replacement, Gaucher's Disease|00
00001241|Parathyroid Hormone|00
00001243|Antineoplastic - Tretinoin|00
00001245|Retinoids and Derivatives (Systemic)|00
00001247|Digoxin Immune Fab|00
00001248|Vasoactive Natriuretic Peptides|00
00001249|Immune Globulin, Gamma (IGG)|00
00001250|Cytomegalovirus (CMV)  Immune Globulin|00
00001251|Tetanus Antitoxin|00
00001252|Diphtheria Antitoxin|00
00001253|Botulism Antitoxin|00
00001254|Gas-Gangrene Antitoxin|00
00001255|Nitroprusside Sodium|00
00001256|Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics|00
00001257|Varicella-Zoster Immune Globulin|00
00001259|Vascular Endothelial Growth Factor(VEGF) Monoclonal Antibody|00
00001260|Antineoplastic - Proteasome Enzyme Inhibitors|00
00001262|Folate Antagonists|00
00001263|Monoclonal Antibodies To Immunoglobulin E (IgE)|00
00001264|Antineoplastic Antibody/Radioactive-Drug Complexes|00
00001265|Acetaminophen Poisoning Antidotes|00
00001266|Metabolic Disease Enzyme Replacement, Fabry's Disease|00
00001267|Calcimimetic, Parathyroid Calcium Recep Sensitivity Enhancer|00
00001268|Antineoplastic - Estrogens|00
00001269|Sepsis Syndrome Agents - Non-Antibiotic|00
00001273|Antineoplastic - Protein-Tyrosine Kinase Inhibitors|00
00001275|Antiporphyria Factors|00
00001276|Ophthalmic - Photodynamic Therapy Agents|00
00001277|Inhaled Aminoglycosides|00
00001278|Ketolides|00
00001279|Hypotensives - Ganglionic Blockers|00
00001282|Thrombocytosis Agents|00
00001299|Pheochromocytoma treatment agents|00
00001309|Metabolic Disease Enzyme Replacement - Mucopolysaccharidosis|00
00001310|Lymphocyte Immune Globulin|00
00001312|Anti-Narcolepsy and Anti-Cataplexy Agents - Sedative-Type|00
00001313|Rabies Immune Globulin|00
00001319|Typhoid Vaccine|00
00001320|Interferon Gamma|00
00001321|Hepatitis A Virus Vaccine|00
00001322|Hepatitis B Immune Globulin|00
00001323|Histamine Preparations|00
00001324|Barbiturates|00
00001325|Ophthalmic - Anti-Inflammatory, Immunomodulators|00
00001327|Nasal Antibiotics|00
00001332|Vitamin B Complex|00
00001333|Allergenic Extracts/Apitherapy - Hymenoptera Derived Agents|00
00001335|Antiparkinson Adjuvant - Peripheral Dopa-decarboxylase Inhib|00
00001336|Plasma Proteins Which Facilitate Anticoagulation|00
00001337|Metabolic Disease Enzyme Replacement, Severe Comb Immune Def|00
00001338|Antidiarrheal Formulations with Gut Flora Microorganisms|00
00001344|Glucagon and Analogs|00
00001345|Oral treatments for Non-Small Cell Lung Cancer|00
00001347|Topical Immunomodulator - Imidazoquinolinamines|00
00001348|Glatiramer (Multiple Sclerosis)|00
00001349|Oral Antivirals for Chronic Hepatitis B|00
00001350|Antineoplastics - Arsenic Compounds|00
00001351|Methanol or Ethylene Glycol Poisoning Antidote|00
00001354|Analgesic, Neuronal-type Calcium Channel Blocker|00
00001355|Organophosphate Poisoning Antidote|00
00001356|Treatment Induced Mucositis Agents|00
00001357|Post Radiation Exposure Treatments|00
00001358|Antihyperglycemic, Incretin Mimetic Agent|00
00001359|Antihyperglycemic Hormone Analogs|00
00001360|Immunosuppressants - Calcineurin Inhibitors|00
00001361|Immunosuppressants - Antiproliferative Agents|00
00001362|Immunosuppressants - Monoclonal and Polyclonal Antibodies|00
00001364|Selenium|00
00001366|Cyanide Poisoning Antidotes|00
00001367|Heparin Antagonists|00
00001368|Antifibrinolytics|00
00001370|Mucopolysaccharidosis VI (MPS VI) Treatment Agents|00
00001371|Mucopolysaccharidosis I (MPS I) Treatment Agents|00
00001372|Abacavir|00
00001373|Lamivudine|00
00001374|Zidovudine|00
00001375|Tenofovir|00
00001377|Emtricitabine|00
00001378|Didanosine (DDI)|00
00001379|Zalcitabine (DDC)|00
00001380|Stavudine (D4T)|00
00001381|RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides|01
00001382|Glycylcyclines|00
00001384|Japanese Encephalitis Vaccine|00
00001386|Antiviral-HIV Boosted Protease Inhibitors|01
00001388|Thalidomide and Derivative Immunomodulators|00
00001389|Coenzyme Q10|00
00001390|Iron Chelating Agents|00
00001391|Hair Growth Inhibitors, Topical|00
00001392|Rotavirus Vaccines|00
00001393|Ophthalmic - Macular Degeneration Agents|00
00001394|Insulin-like Growth Factor-1 (IGF-1) agents|00
00001395|Antifungal - Glucan Synthesis Inhibitors|00
00001396|Rectal Local Vasoconstrictors|00
00001400|Anesthetics, Intrathecal|00
00001401|Levocarnitine|00
00001403|Ethanol (Ethyl Alcohol), Intravenous and Injection|00
00001404|Parenteral Solutions Containing Inverted Sugar|00
00001405|Pneumococcal Vaccines|00
00001406|Meningococcal Vaccines - Serogroups A,C,Y,W135|00
00001409|Wound Healing, Topical Growth Factor|00
00001411|Hyaluronidase Enzymes|00
00001412|Antianginal And Anti-Ischemic Agents, Non-Hemodynamic|00
00001420|BCG|00
00001421|Selective Retinoid X Receptor Agonists|00
00001423|Strontium|00
00001426|Choleretics|00
00001427|Nitrofuran Derivatives (Systemic)|00
00001430|Synthetic Immunomodulator Agents (Systemic)|00
00001435|Q Fever Vaccine|00
00001437|Non-Nitrate Coronary Vasodilators|00
00001444|Antidiuretic Hormone Antagonists|00
00001445|Metabolic Disease Enzyme Replacement, Pompe Disease|00
00001446|Phosphonic Acid, Antibacterials|00
00001450|Soybean Oil|00
00001454|Phenylalanine|00
00001462|Antineoplastic - Photosensitizers|00
00001464|Ammonia Inhalants|00
00001465|Respiratory Syncytial Virus Immune Globulin|00
00001467|Human Papillomavirus (HPV) Vaccines|00
00001468|Ammonia Absorption Inhibitors for Hepatic Encephalopathy|00
00001469|Antibiotics for Hyperammonemia|00
00001471|Topical Chelating Agents For Heavy Metals|00
00001472|Macular Degeneration Treatment Agents-VEGF Antagonist Type|00
00001473|Diuretics - Aldosterone Receptor Antagonist|00
00001474|Topical Neutralizing Agents For Hydrogen Fluoride|00
00001476|Mucopolysaccharidosis II (MPS II) Treatment Agents|00
00001477|Bone Morphogenic Agents|00
00001478|Nitrofurazone Topical|00
00001479|Topical Macrolide Antibiotics|00
00001480|Topical Tetracyclines|00
00001481|Topical Sulfonamide Antimicrobials|00
00001482|Beta-Adrenergic Agents Long-Acting (Inhaled)|00
00001483|Steroid Hormone Supplements|00
00001484|Wilson's Disease Treatment Agents|00
00001487|Staphylococcal Vaccines|00
00001488|Histone deacetylase (HDAC) inhibitors|00
00001490|Topical Antineoplastic Retinoids|00
00001491|Antihyperglycemic-dipeptidyl peptidase-4 (DPP-4) Inhibitors|00
00001492|Betaine|00
00001493|Agents to treat Aphthous Stomatitis|00
00001494|Agents to treat Metabolic Acidosis|00
00001495|Phenolic Antiseptics|00
00001496|Aminopyridines for Neurological Disorders|00
00001500|Parenteral Solutions Containing Fructose|00
00001501|Chromium|00
00001502|Molybdenum|00
00001506|Dextrose, Oral Formulations|00
00001514|Keratolytics (Topical), General|02
00001515|Biotin, Systemic|00
00001516|Teicoplanin|00
00001519|Saw Palmetto|00
00001520|Agents to Treat Erectile Dysfunction, cGMP-Type|00
00001521|Agents to Treat Erectile Dysfunction, Prostaglandin-Type|00
00001522|Agents to Treat Erectile Dysfunction,Adrenergic Blocking-Typ|00
00001523|Agents to Treat Erectile Dysfunction, Apomorphine-Type|00
00001524|Niacin/Niacinamide (Vitamin B-3)|00
00001526|Topical Nitroimdazoles|00
00001528|Procaine, Systemic|00
00001529|Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type|01
00001530|Smoking Deterrents - Nicotinic|01
00001531|Anticonvulsants, GABA-derivative-type|00
00001532|Lobeline|00
00001534|Renin Inhibitors, Direct|00
00001536|Complement Inhibitors|00
00001537|Respiratory Stimulants|00
00001538|Acetylcysteine, Systemic|00
00001539|Sodium Chloride (Oral Supplement)|00
00001540|Non-Steroidal Anti-Inflammatory Agents (NSAID), Topical|00
00001541|Pleuromutilin Derivatives, Topical|00
00001542|Osteoporosis Agents, Estrogenic|00
00001544|Antidote - GI Insoluble Metal Chelators|00
00001547|Protein C Replacement|00
00001548|Agents with unrelated but significant Factor C Activity|00
00001549|Antineoplastic - mTOR Kinase Inhibitors|00
00001550|Protein Kinase Inhibitors for Renal Cell Carcinoma|00
00001552|Pulmonary Antihypertensive Agents, cGMP pathway|00
00001553|Antiviral-HIV (Antiretroviral) CCR5 Co-Receptor Antagonist|00
00001554|Topical Methenamine (Antibacterial/Antifungal)|00
00001556|Agents to Treat Opioid (Opiate) Dependence|00
00001557|Multiple Sclerosis Agents, General|00
00001560|Antiviral-HIV-1 Integrase Strand Transfer Inhibitors|00
00001561|Antineoplastic-Epothilones and Analogs|00
00001563|Topical Silver Sulfadiazine|00
00001565|Phenylketonuria Tx - Cofactors of Phenylalanine Hydroxylase|00
00001566|Topical Sinecatechins|00
00001568|Immunosuppressants - mTOR Inhibitors|00
00001569|Immunosuppressants - Calcineurin and mTOR Inhibitors|01
00001575|Intrapleural Sclerosing Agents|00
00001579|Anti-Inflammatory - Interleukin 1 Receptor Antagonist|00
00001580|Selective Cholesterol Absorption Inhibitor|00
00001581|Anticonvulsant - Phenyltriazine Derivatives|00
00001582|Anticonvulsant - Carbamates|00
00001583|Anticonvulsant - GABA Modulators|00
00001584|Anticonvulsant - Sulfonamide Derivatives|00
00001585|Anticonvulsant - Pyrrolidine Derivatives|00
00001586|Anticonvulsant - Monosaccharide Derivatives|00
00001587|Anticonvulsant - Triazole Derivatives|00
00001588|Anticonvulsant - Cyclic Sulfonamide Derivatives|00
00001589|Opioid Antagonists, Peripherally-Acting|00
00001590|Selective I(f) Current Inhibitors - SA Node|00
00001591|Prostatic Hypertrophy Agt-Type I, II 5Alpha Reductase Inhib|00
00001592|Cephalosporins - 5th Generation|00
00001593|Bradykinin B2 Receptor Antagonists (Acute)|00
00001594|Dopamine-Depleting Agents|00
00001595|C1 Esterase Inhibitors (Acute)|00
00001596|Arginine Solutions, Single agent, Injectable|00
00001598|Reversal of NM Blocking-Selective Relaxant Binding Type|00
00001599|Reversal Agents for Neuromuscular Blocking Drugs|00
00001600|Inhaled Polymyxins and Derivatives|00
00001602|CXCR4 Chemokine Receptor Antagonists|00
00001605|Anticonvulsant - Functionalized Amino Acid|00
00001606|Monoclonal Antibody, Human Interleukin 12/23 Inhibitors|00
00001607|Carbocysteine, Systemic|00
00001608|Antidepressant Melatonin Receptor Agonist, 5HT2C Antagonist|00
00001609|Opioid Analgesics- ER (with all antitussive opiates)|00
00001612|Monoclonal Antibody, Human Interleukin 6 Inhibitors|00
00001613|Loop Diuretics|00
00001614|Thiazide and Related Diuretics|00
00001615|Selective Serotonin Agonists 5-HT1 (Triptans)|00
00001616|Nitrates - Immediate Release - Acute Rescue|00
00001617|Influenza A (H1N1) Vaccine|00
00001618|DP1 Receptor Antagonists|00
00001620|Telavancin|00
00001621|Plasma Kallikrein Inhibitors (Acute)|00
00001622|Anthrax Vaccine|00
00001623|Multiple Sclerosis Agent - Potassium Channel Blocker|00
00001624|Collagenase Enzymes, Injectable|00
00001625|Antineoplastic - Muramyl Dipeptide (MDP) Derivatives|00
00001626|Antipsoriatics, Topical|02
00001627|Antineoplastic - Immunotherapy for Prostate Cancer|00
00001628|Antineoplastic - Immunotherapy, Therapeutic Vaccines|00
00001629|Phosphodiesterase-4 (PDE4) inhibitors|00
00001630|Sphingosine 1-Phos Recep Mod for Mult.Sclerosis/Inflam.Bowel|00
00001631|Antihyperglycemic - Dopamine Receptor Agonists|00
00001632|Halochondrin B Analogs, Microtubule Inhibitor|00
00001633|Opioid Analgesics- IR (with all antitussive opiates)|00
00001634|Low dose Aspirin (81 mg or less)|00
00001636|Factor XIII|00
00001639|Immunomodulator, B-Lymphocyte Stimulator (BLyS)-Spec  Inhib|00
00001640|Antineoplastic-Cytotoxic T-Lymp. antigen (CTLA-4),R-MC Antib|00
00001641|Hyperuricemia Agents (antimitotic)|00
00001642|Human Chorionic Gonadotropin (hCG)|00
00001643|Follicle-Stimulating Hormone (FSH)|00
00001644|Luteinizing Hormones (hLH)|00
00001645|Agents to Treat Restless Legs Syndrome (RLS)|00
00001646|Antirheumatic Agents (Biologic DMARDS)|00
00001647|Chloroquines|00
00001648|Pyrimidine Synthesis Inhibitors|00
00001649|Hepatitis C Virus NS3/4A Serine Protease Inhibitors|00
00001651|Anticonvulsant - Potassium Channel Opener|00
00001652|Fertility Stimulating Preparations, Non-FSH|00
00001653|Luteinizing Hormone Releasing Hormone|00
00001654|Selective T-cell (lymphocyte) costimulation blocker|00
00001657|Antineoplastic-Bispecific Trifunc Rec. MC Antib, Intraperit.|00
00001658|Mushroom Poisoning Antidotes|00
00001660|Substance P-Neurokinin 1 (NK1) Receptor Antagonists|00
00001661|Selective Serotonin 5-HT3 Antagonists|00
00001662|Topical Vitamin D Analogs|00
00001663|Antineoplastic - Janus Kinase (JAK) Inhibitors|00
00001665|Ethamsylate|00
00001668|Antiprotozoal Antimony Compounds|00
00001669|Methotrexate Rescue Agents - Carboxypeptidase G2 Type|00
00001671|Aminoglycoside Implant|00
00001672|Antineoplastic - Hedgehog Pathway Inhibitors|00
00001673|Cystic Fibrosis Transmemb. Conduct. Reg. (CFTR) Potentiators|00
00001674|Antihyperglycemic-Glucocorticoid Receptor Blocker (GR-II)|00
00001675|Antidepressant Serotonin Reuptake Inhib. (SSRIs,SNRIs,SDRIs)|00
00001676|Antineoplastic - Acridine derivatives|00
00001677|Cholera Vaccine|00
00001678|Topical Heparinoids|00
00001679|Tick-Borne Encephalitis Vaccine|00
00001680|Tumor Necrosis Factor|00
00001681|Cholinesterase Inhibitors|00
00001682|Selective Progesterone-Receptor Modulators|00
00001683|Heparinoids, Rectal|00
00001684|Nitroimidazole, Dental|00
00001688|Smallpox Vaccine|00
00001689|Immunostimulant Agents, Bacterial|00
00001697|Sulbactam|00
00001698|Inhaled Expectorants|00
00001699|Diacerein|00
00001701|Fusidic Acid Antibiotics, Systemic|00
00001702|Ophthalmic - Antioxidant, Local Agents|00
00001703|Tribenoside|00
00001704|NSAID,local,mucous membrane|00
00001705|Antineoplastic-VEGF-A and B,PlGF Growth Factor Inhibitor|00
00001706|Leprostatics (Systemic single ingredient)|02
00001707|Eye Preparations containing Vitamin A|00
00001708|Overactive Bladder Agents-Beta 3 Adrenergic Receptor Agonist|00
00001709|Anticonvulsant - AMPA-Type Glutamate Receptor Antagonists|00
00001711|Ophthalmic Anticataract Agents|00
00001712|sodium dichloroacetate|00
00001713|Antisecretory Agents|00
00001714|Analgesic - Volatile Inhaled Agents|00
00001715|Ophthalmic - Cystine Depleting Agents|00
00001716|Ophthalmic - Proteolytic Enzyme Agents|00
00001717|Janus Kinase (JAK) Inhibitors|00
00001718|Antineoplastic - Cephalotaxines|00
00001719|Antiarrhythmic - Atrial Repolarization Delaying Agents|00
00001721|Antihyperlipidemic-eicosapentaenoic acid (EPA) derivatives|00
00001722|Diarylquinoline Anti-Mycobacterial Antibiotics|00
00001723|Antidiarrheal - Gastrointestinal Chloride Channel Inhibitors|00
00001724|Short Bowel Syndrome-glucagon-like peptide-2 (GLP-2) analog|00
00001725|Microsomal Triglyceride Transfer Protein Inhibitors|00
00001728|Local/Urethral Anesthetic|00
00001729|Allergenic Extract-Grass Pollens|03
00001730|Analgesic - Selective Neuronal Potassium Channel Openers|00
00001731|Antihyperlipidemic - apolipoprotein Synthesis Inhibitors|00
00001732|Antineoplastic - HER2 Inhibitors|00
00001733|Antihyperglycemic-Sod/Gluc Cotransport-2 (SGLT2) Inhibitors|00
00001734|Pulmonary Fibrosis Treatment Agents - Antifibrotic Therapy|00
00001735|Iron, Injectable|00
00001737|Antihyperlipidemics - Nicotinic Acid and Derivatives|00
00001738|Adenovirus Type 4 Vaccine|00
00001739|Adenovirus Type 7 Vaccine|00
00001740|Antifungal - Azoles Systemic|00
00001741|Treatments for Rosacea Erythema|00
00001745|Intravesical (bladder) hyaluronate|00
00001746|Topical Antineoplastic Alkylating Agents|00
00001749|Simethicone|00
00001750|Hepatitis C Nucleos(t)ide Analog NS5B Polymerase Inhibitors|00
00001751|Hypertonic Sodium Chloride Solutions|00
00001752|Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway|00
00001753|Overactive Bladder Agents|01
00001754|Surfactant Laxatives|00
00001758|Mucopolysaccharidosis IVA (MPS IVA) Treatment Agents|00
00001759|Multiple Sclerosis Agent - CD52 Specific Monoclonal Antibody|00
00001760|Anticonvulsant - Iminostilbene Derivatives|00
00001761|Oral Cystinosis Therapy, Cystine Depleting Agents|00
00001762|Cystic Fibrosis - Osmotic Agents Inhaled|00
00001773|Leptin Hormone Analogs|00
00001777|Allergenic Extract-Weed Pollens|03
00001781|Anticonvulsants - Bromide Type|00
00001783|Pharmacoenhancer - Cytochrome P450 Inhibitors|00
00001784|Antiplatelet and Antithrombotic Drugs (Selected Group 2)|00
00001785|Integrin Receptor Antagonists|00
00001791|Antineoplastic - EGF Receptor 2 (HER2) Subdomain II Blocker|00
00001792|von Willebrand factor|00
00001793|Cannabis and Cannabinoid Receptor Agonists|00
00001794|Attention Deficit Hyperactivity Disorder (ADHD) Agents|00
00001795|Antiviral-HIV Cytidine Analogue Nucleoside RT Inhibitors|00
00001796|Antiviral-HIV Fixed-Dose Combinations|00
00001797|Nitroimidazole Vaginal|00
00001798|Psoralens, Systemic|00
00001799|Alpha2-adrenoceptor Agonists|00
00001800|Chemoprotectives - Cardioprotective Intracellular Chelators|00
00001801|Antineoplastic - Phosphatidylinositol 3-Kinase Delta Inhib.|00
00001803|Allergenic Extract-Tree Pollens|03
00001804|Antineoplastic - Anti-Programmed Death-(PD-1/L1) MC Antibody|00
00001805|Antiviral - Influenza B|00
00001806|Hepatitis C - NS5A Replication Complex Inhibitors|00
00001807|Cobalt|00
00001808|Antimalarials - Artemisinin and Derivatives|00
00001809|Amyloidosis Agents - Protein Stabilizers|00
00001810|Antineoplastic-Poly (ADP-Ribose) polymerase (PARP) inhibitor|00
00001811|Hepatitis C Non-Nucleoside NS5B Polymerase Inhibitors|00
00001812|Nitroimidazole Derivatives Anti-Mycobacterial Antibiotics|00
00001813|Antineoplastic- Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors|00
00001814|Monoclonal Antibody, Interleukin-17A Antagonists|00
00001815|Duchenne Muscular Dystrophy - Nonsense Mutation Suppressor|00
00001816|Antineoplastic - Anti-GD2 Ganglioside Monoclonal Antibody|00
00001817|Gene Therapy Agent - Lipoprotein Lipase (LPL)|00
00001818|Benzodiazepines-Injectable|00
00001819|Benzodiazepines-Non-Injectable Formulations (oral etc.)|00
00001820|Aesthetic Agents for Subcutaneous Adipose Lysis|00
00001821|Cystic Fibrosis Transmemb. Conduct. Reg. (CFTR) Correctors|01
00001822|Neprilysin Inhibitors|00
00001823|Antihyperlipidemic - PCSK9 Inhibitors|00
00001825|Metabolic Disorder - Hydrogen Sulfide Insufficiency Agents|00
00001826|HSDD Agents-Mixed Serotonin Agonist/Antagonists|00
00001828|Hereditary Orotic Aciduria Treatment Agents|00
00001829|Agents to Tx Periodic Paralysis-Carbonic Anhydrase Inhibitor|00
00001830|Anticoagulant Reversal Agent for Dabigatran|00
00001831|Metabolic Disease Enzyme Replacement - Hypophosphatasia|00
00001832|Factor X|00
00001833|Antineoplastic-Immunotherapy Virus-Based Agents|00
00001836|Metabolic Enzyme Replacemnt-Lysosomal Acid Lipase Deficiency|00
00001837|Antineoplastic - MEK1 and MEK2 Kinase Inhibitors|00
00001838|Monoclonal Antibody, Human Interleukin 5 Antagonist|00
00001839|Antineoplastic - Anti-CD38 Monoclonal Antibody|00
00001840|Antineoplastic-Anti-SLAMF7 Monoclonal Antibody Agents|00
00001841|Antineoplastic - Anaplastic Lymphoma Kinase (ALK) Inhibitors|00
00001842|Fluorouracil and Related Rescue Agents|00
00001843|uridine|00
00001844|PAH Agents- Endothelin Receptor Antagonists|00
00001845|Pulmonary Antihypertensive Agents - Prostacyclin-type|00
00001846|Anti-Androgen - Androgen Synthesis Inhibitors|00
00001847|Botulism Immune Globulin, Human|00
00001849|Inhaled Monobactams|00
00001850|Antineoplastic - B-cell lymphoma-2 (BCL-2) inhibitors|00
00001851|Antineoplastic - BRAF Kinase Inhibitors|00
00001852|Selective serotonin 5-HT2A inverse agonists (SSIA)|00
00001853|Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents|00
00001854|Farnesoid X Receptor (FXR) Agonists, Bile Acid Analogs|00
00001855|Anti-Obesity - GLP-1 and Dual GIP and GLP-1 Receptor Agonist|00
00001856|Anti-Obesity - Serotonin 2C Receptor Agonists|00
00001857|Agents for Corneal Collagen Cross-Linking|01
00001858|Meningococcal Vaccines - Serogroup B|00
00001859|Duchenne Muscular Dystrophy-Exon Skipping Antisense Oligonuc|00
00001860|Anthrax Monoclonal Antibody|00
00001861|Platelet-derived Growth Factor Rec (PDGFR)alpha blocker MCab|00
00001862|Clostridioides (Clostridium) difficile Monoclonal Antibody|00
00001863|Glucocorticoid Suppression Test Agents|00
00001864|Topical Phosphodiesterase-4 (PDE4) inhibitors|00
00001865|Genetic Disorder Therapy - SMN Protein Deficiency Treatment|00
00001866|Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC|00
00001867|Antidiarrheal - Tryptophan Hydroxylase Inhibitor|00
00001868|Multiple Sclerosis Agent - CD20 Specific Monoclonal Antibody|00
00001869|Eczema Agents Systemic Interleukin-4 (IL-4Ra)Antag.McAb|00
00001870|Antihyperglycemics, Incretin-Based Therapies|00
00001872|Drugs to Treat Neuronal Ceroid Lipofuscinosis type 2 (CLN2)|00
00001873|Amyotrophic Lateral Sclerosis Agents - Antioxidants|00
00001874|Monoclonal Antibody, Interleukin 23 Antagonists|00
00001875|Pharmacological Chaperone - Alpha-galactosidase A stabilizer|00
00001876|Chemoprotectives - Agents for Chemotherapy Extravasation|00
00001877|Antineoplastic - Isocitrate Dehydrogenase-2 Inhibitor (IDH2)|00
00001878|Antineoplas-CD22 Specific Antibody/Cytotoxic Antibiotic Conj|00
00001879|Antineoplastic - CAR-T/TCR-T cell immunotherapy|00
00001881|Varicella Vaccines|00
00001882|Bisphosphonates|00
00001883|Mucopolysaccharidosis VII (MPS VII) Treatment Agents|00
00001886|Ophthalmic - Retinal Enzyme Replacement|00
00001887|Nasal Anesthetics|00
00001888|Renin-Angiotensin-Aldosterone System (RAAS) Hormones|00
00001889|Antiparkinsonian Amantadine Formulations|00
00001890|Antiretroviral - Anti-CD4 Domain 2 Monoclonal Antibody|00
00001893|All Aspirin Formulations regardless of strength|01
00001894|Intrauterine Devices (IUDs)|00
00001895|Fibroblast Growth Factor 23 (FGF23) Inhibitors, Monoclon Ab|00
00001896|Spleen/Bruton's Tyrosine Kinase Inhibitors|00
00001897|Anticoagulant Reversal Agent for Factor Xa Inhibitors|00
00001898|Phenylketonuria (PKU) Treatment Agents|00
00001899|Buprenorphine|00
00001900|Antipsychotics (excluding select aripiprazole formulations)|00
00001901|Hypertrophic Cardiomyopathy Treatment Agents, Ablative|00
00001902|Antineoplastic - Isocitrate Dehydrogenase-1 Inhibitor (IDH1)|00
00001903|Ophthalmic (Eye) Anti-Allergy Agent, Osmolyte Type|00
00001904|Ophthalmic (Eye) Rifamycin Antibiotics|00
00001905|Otic (Ear) Rifamycin Antibiotics|00
00001906|Topical Gaba-derivative Agent|00
00001907|Topical Anticholinergic Hyperhidrosis Treatment Agents|00
00001908|Antineoplastic - Radiolabeled Meta-iodobenzylguanidine (MIBG|00
00001909|Amyloidosis Agents - Transthyretin (TTR) Suppression|00
00001910|Plasma Kallikrein Inhibitor, Recombinant Monoclonal Antibody|00
00001911|Antiviral - Variola (Smallpox) Virus Treatment|00
00001912|Salicylate containing Oral Gels|00
00001913|Antineoplastic CD22 Directed Antibody & Cytotoxin Conjugate|00
00001914|Asthma Tx- Interleukin-4(IL-4) Receptor Alpha Antagonist,MAb|00
00001916|Influenza Antiviral Agents - PA  Endonuclease Inhibitor|00
00001917|Anticholinergic Agents Short-Acting (Inhaled)|00
00001918|Anticholinergic Agents Long-Acting (Inhaled)|00
00001919|Drugs to treat Vertigo|00
00001920|Ophthalmic Human Nerve Growth Factor (hNGF)|00
00001921|Antineoplastic - Tropomyosin Receptor Kinase (TRK) Inhibitor|00
00001922|Immunosuppressive -  Interferon Inhibitor, Monoclonal Ab|00
00001923|C1 Esterase Inhibitors (Prophylaxis)|00
00001925|Acute Hereditary Angioedema Treatment Agents|00
00001926|Prophylaxis Hereditary Angioedema Treatment Agents|00
00001927|Narcolepsy Therapy - H3-Receptor Antagonist/Inverse Agonist|00
00001928|Agents to treat Thrombotic Thrombocytopenic Purpura (TTP)|00
00001929|Antineoplastic - CD123-Directed Cytotoxin Conjugate|00
00001930|Antidepressant NMDA Receptor Antagonists|00
00001931|Narcolepsy Therapy-Dopamine and Norepinephrine Reuptake Inh.|00
00001932|Antidepressant Neuroactive Steroid GABA-A Receptor Modulator|00
00001933|Gene Therapy Agents - SMN Protein Deficiency|00
00001934|Antineoplastic - Phosphatidylinositol 3-Kinase Alpha Inhib.|00
00001935|Calcium Channel Blockers, oral|00
00001936|Calcium Channel Blockers, intravenous|00
00001937|Antineoplastic-Selective Inhibitors of Nuclear Export(SINE)|00
00001938|Hypoactive Sexual Desire Disorder (HSDD) Treatment Agents|00
00001939|HSDD Agents-Non-Selective Melanocortin Receptor Agonist|00
00001940|Hyaluronidase Enzymes, Intraocular|00
00001941|Migraine Prevention Medications|00
00001942|Cluster Headache Medications|00
00001943|Topical Progestins|00
00001944|Antineoplastic - FMS-like Tyrosine Kinase (FLT) Inhibitor|00
00001945|Pleuromutilin Derivatives, Systemic|00
00001946|Antiparkinson Adjuvant - Adenosine Receptor Antagonist|00
00001947|Dengue Vaccine|00
00001948|Erythroid (RBC) Maturation Agents|00
00001949|Monoclonal Antibody - Selectin Inhibitors|00
00001950|Topical Histamine Preparations|00
00001951|AHP Agents - ALAS1 mRNA Degradation|00
00001952|Sickle Hemoglobin (HbS) Polymerization Inhibitor|00
00001953|Cephalosporin Antibiotics - Siderophore|00
00001955|Perianal Fissure Rectal Treatment|00
00001956|Metabolic Disease Enzyme Replacement, Alpha-Mannosidosis|00
00001957|Insulin-like Growth Factor-1 Receptor Inhibitor (IGF-1R) mAb|00
00001958|Antineoplastic - Protein Methyltransferase (PMT) Inhibitors|00
00001959|Allergenic Extract-Peanut|02
00001960|Antihyperlipidemic - ATP-Citrate Lyase (ACLY) Inhibitor|00
00001961|Antiglaucoma Implant|00
00001962|Ebola Vaccine|00
00001963|Antineoplastic-Fibroblast Growth Factor Receptor (FGFR) Inh.|00
00001964|Antineoplastic-TROP2 Directed Antibody-Topoisomerase I Inhib|00
00001965|Boron Supplements|00
00001966|Antiretroviral HIV - CD4 Attachment Inhibitors|00
00001968|Smoking Deterrents - Nicotine Patches, Transdermal|00
00001969|Antineoplastic - Systemic Elongation Factor (EF) Protein Inh|00
00001970|Stem Cell Therapy|00
00001971|Ophthalmic - P2Y2 Purinergic Receptor Agonists|00
00001972|Topical Antiandrogens|00
00001973|Antiviral Monoclonal Antibodies - Zaire Ebola Virus|00
00001974|COVID-19 (SARS-CoV-2) Vaccines|00
00001977|Anti-Obesity - Melanocortin 4 (MC4) Receptor Agonist|00
00001978|Oxalosis Agent - Oxalate Inhibitor|00
00001979|COVID-19 (SARS-CoV-2) Antiviral Agents-Nucleotide Analog|00
00001980|Progeria Syndrome Treatment Agents|00
00001983|Soluble Guanylate Cyclase (sGC) Stimulators|00
00001984|Antihyperlipidemic - Angiopoietin-like 3 (ANGPTL3) Inhibitor|00
00001985|Metabolic Disease Enzyme Replacement, MoCD|00
00001986|Digestive Enzyme Inhibitors|00
00001988|Antineoplastic - Bispecific EGFR and MET Rec Inhibitor MC Ab|00
00001990|Antineoplastic - Kirsten Rat Sarcoma (KRAS)Protein Inhibitor|00
00002055|Alzheimer's Disease Agents - Amyloid Directed MC Antibody|00
00002525|Ileal Bile Acid Transporter (IBAT) Inhibitor|00
00002527|Immunomodulator - Rho Kinase Inhibitor|00
00002639|Antineoplastic - Hypoxia Inducible Factor (HIF) Inhibitors|00
00002807|Analgesic Opioid Agonists - Antipruritic|00
00002862|Antineoplas-Tissue Factor Directed Ab-Microtub Disrupt Conj|00
00002863|Topical Janus Kinase (JAK) Inhibitors|00
00002873|Glycopyrrolate|00
00002884|Nasal Preparations - Nicotinic Receptor Partial Agonist|00
00002936|Bone Formation Stimulating Agents - Natriuretic Peptide|00
00002937|Hematopoietic-Hypoxia Inducible Factor Prolyl Hydroxyl Inhib|00
00002978|COVID-19 (SARS-CoV-2) Antiviral-Main Protease Inhibitors|00
00002980|Eczema Agents Systemic Interleukin-13 (IL-13)Antag.mAb|00
00002982|Asthma Therapy - Thymic Stromal Lymphopoietin Inhibitor, MAb|00
00002985|Antineoplastic - Immunotherapy, T-cell Engager|00
00002987|SARS-CoV-2 Monoclonal Antibodies|00
00002988|Antihemolytic - Pyruvate Kinase (PK) Activator|00
00002995|Antineoplastic-Anti-Lymphocyte Activation Gene-3 (LAG-3) MAb|00
00003007|Cardiac Myosin Modulators (Inhibitors and activators)|00
00003215|Hepatitis D - NTCP inhibitor|00
00003225|Amyotrophic Lateral Sclerosis Agents - Others|00
00003226|Hematopoietic Agents - Hematopoietic Gene Therapy Agents|00
00003280|Metabolic Disease Enzyme Replacement - ASMD|00
00003349|Antiretroviral - Capsid Inhibitors|00
00003350|LHrH(GNrH) Antagonist/Agonist to Treat Prostatic Cancer|00
00003353|COVID-19 (SARS-CoV-2) Antiviral Agents|00
00003356|Asthma Therapy - Biologics/Monoclonal Antibodies|00
00003359|Fecal Microbiota Therapies|00
00003360|Respiratory Syncytial Virus (RSV) Vaccine|00
00003373|Antiviral-HIV PrEP Therapies|00
00003375|Peroxisome Proliferator-Activated Receptor (PPAR) Agonist|00
00003376|Metabolic Modifier - Neimann Pick Disease Type C (NPC)|00
00003380|chikungunya vaccine|00
00003382|Dermatological - Gene Therapy Agents|00
00003405|Antiviral - CMV and/or HSV infection oral coverage|00
00003406|Iron (all routes oral and injectable)|03
00003407|Menopausal Symptoms Suppressant - Neurokinin Receptor Antago|00
00003408|Systemic Xerostomia Agents|00
00003409|Antineoplastic - Menin Inhibitors|00
